Literature DB >> 34073578

Ceramide and Related Molecules in Viral Infections.

Nadine Beckmann1, Katrin Anne Becker1.   

Abstract

Ceramide is a lipid messenger at the heart of sphingolipid metabolism. In concert with its metabolizing enzymes, particularly sphingomyelinases, it has key roles in regulating the physical properties of biological membranes, including the formation of membrane microdomains. Thus, ceramide and its related molecules have been attributed significant roles in nearly all steps of the viral life cycle: they may serve directly as receptors or co-receptors for viral entry, form microdomains that cluster entry receptors and/or enable them to adopt the required conformation or regulate their cell surface expression. Sphingolipids can regulate all forms of viral uptake, often through sphingomyelinase activation, and mediate endosomal escape and intracellular trafficking. Ceramide can be key for the formation of viral replication sites. Sphingomyelinases often mediate the release of new virions from infected cells. Moreover, sphingolipids can contribute to viral-induced apoptosis and morbidity in viral diseases, as well as virus immune evasion. Alpha-galactosylceramide, in particular, also plays a significant role in immune modulation in response to viral infections. This review will discuss the roles of ceramide and its related molecules in the different steps of the viral life cycle. We will also discuss how novel strategies could exploit these for therapeutic benefit.

Entities:  

Keywords:  HIV-1; IAV; SARS-CoV-2; acid sphingomyelinase; antiviral therapies; ceramide; immunomodulation; lipid-rafts; sphingolipids; viral infection; α-galactosylceramide

Year:  2021        PMID: 34073578     DOI: 10.3390/ijms22115676

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  220 in total

1.  Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model.

Authors:  Takuya Umehara; Masayuki Sudoh; Fumihiko Yasui; Chiho Matsuda; Yukiko Hayashi; Kazuaki Chayama; Michinori Kohara
Journal:  Biochem Biophys Res Commun       Date:  2006-05-24       Impact factor: 3.575

2.  The Trojan exosome hypothesis.

Authors:  Stephen J Gould; Amy M Booth; James E K Hildreth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-28       Impact factor: 11.205

3.  Cellular Protein Kinase D Modulators Play a Role during Multiple Steps of Herpes Simplex Virus 1 Egress.

Authors:  Élisabeth Roussel; Roger Lippé
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

4.  Sphingomyelin synthase 2, but not sphingomyelin synthase 1, is involved in HIV-1 envelope-mediated membrane fusion.

Authors:  Yasuhiro Hayashi; Yoko Nemoto-Sasaki; Takashi Tanikawa; Saori Oka; Kiyoto Tsuchiya; Kouta Zama; Susumu Mitsutake; Takayuki Sugiura; Atsushi Yamashita
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

5.  Characterization of the early steps of human parvovirus B19 infection.

Authors:  Silva Quattrocchi; Nico Ruprecht; Claudia Bönsch; Sven Bieli; Christoph Zürcher; Klaus Boller; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

6.  HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide.

Authors:  Annette Alfsen; Morgane Bomsel
Journal:  J Biol Chem       Date:  2002-04-08       Impact factor: 5.157

7.  Vaccination with human papillomavirus-18 E1 protein plus α-galactosyl-ceramide induces CD8+ cytotoxic response and impairs the growth of E1-expressing tumors.

Authors:  Alfredo Amador-Molina; Cesar Trejo-Moreno; Damaris Romero-Rodríguez; Isabel Sada-Ovalle; Enrique Pérez-Cárdenas; Edmundo Lamoyi; José Moreno; Marcela Lizano
Journal:  Vaccine       Date:  2019-01-28       Impact factor: 3.641

8.  Use of Acid Ceramidase and Sphingosine Kinase Inhibitors as Antiviral Compounds Against Measles Virus Infection of Lymphocytes in vitro.

Authors:  Anika Grafen; Fabian Schumacher; Janice Chithelen; Burkhard Kleuser; Niklas Beyersdorf; Jürgen Schneider-Schaulies
Journal:  Front Cell Dev Biol       Date:  2019-10-01

9.  Differential activation of acid sphingomyelinase and ceramide release determines invasiveness of Neisseria meningitidis into brain endothelial cells.

Authors:  Alexander Simonis; Sabrina Hebling; Erich Gulbins; Sibylle Schneider-Schaulies; Alexandra Schubert-Unkmeir
Journal:  PLoS Pathog       Date:  2014-06-12       Impact factor: 6.823

10.  A global lipid map defines a network essential for Zika virus replication.

Authors:  Hans C Leier; Jules B Weinstein; Jennifer E Kyle; Joon-Yong Lee; Lisa M Bramer; Kelly G Stratton; Douglas Kempthorne; Aaron R Navratil; Endale G Tafesse; Thorsten Hornemann; William B Messer; Edward A Dennis; Thomas O Metz; Eric Barklis; Fikadu G Tafesse
Journal:  Nat Commun       Date:  2020-07-21       Impact factor: 14.919

View more
  6 in total

Review 1.  Mechanisms of action of fluvoxamine for COVID-19: a historical review.

Authors:  Yaeko Hashimoto; Takuji Suzuki; Kenji Hashimoto
Journal:  Mol Psychiatry       Date:  2022-01-07       Impact factor: 13.437

Review 2.  Diversity of Lipid Function in Atherogenesis: A Focus on Endothelial Mechanobiology.

Authors:  Stanislav Kotlyarov
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

Review 3.  Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19.

Authors:  Mohamed Mahdi; Levente Hermán; János M Réthelyi; Bálint László Bálint
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

4.  The Sphingolipid Inhibitors Ceranib-2 and SKI-II Reduce Measles Virus Replication in Primary Human Lymphocytes: Effects on mTORC1 Downstream Signaling.

Authors:  Janice Chithelen; Hannah Franke; Nora Länder; Anika Grafen; Jürgen Schneider-Schaulies
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

Review 5.  Acid sphingomyelinase/ceramide system in schizophrenia: implications for therapeutic intervention as a potential novel target.

Authors:  Feifei Zhao; Hongjun Tian; Chuanjun Zhuo; Jiayue Chen; Qianchen Li; Lei Yang; Jing Ping; Ranli Li; Lina Wang; Yong Xu; Ziyao Cai; Xueqin Song
Journal:  Transl Psychiatry       Date:  2022-06-23       Impact factor: 7.989

Review 6.  Recent Progress in the Development of Opaganib for the Treatment of Covid-19.

Authors:  Charles D Smith; Lynn W Maines; Staci N Keller; Vered Katz Ben-Yair; Reza Fathi; Terry F Plasse; Mark L Levitt
Journal:  Drug Des Devel Ther       Date:  2022-07-12       Impact factor: 4.319

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.